313 related articles for article (PubMed ID: 35399942)
21. Biomarkers of Diabetic Retinopathy.
Ting DS; Tan KA; Phua V; Tan GS; Wong CW; Wong TY
Curr Diab Rep; 2016 Dec; 16(12):125. PubMed ID: 27778251
[TBL] [Abstract][Full Text] [Related]
22. Metabolomics Analysis of Human Vitreous in Diabetic Retinopathy and Rhegmatogenous Retinal Detachment.
Haines NR; Manoharan N; Olson JL; D'Alessandro A; Reisz JA
J Proteome Res; 2018 Jul; 17(7):2421-2427. PubMed ID: 29877085
[TBL] [Abstract][Full Text] [Related]
23. Plasma metabolomic profiling of proliferative diabetic retinopathy.
Zhu XR; Yang FY; Lu J; Zhang HR; Sun R; Zhou JB; Yang JK
Nutr Metab (Lond); 2019; 16():37. PubMed ID: 31160916
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive metabolic profiling of diabetic retinopathy.
Han X; Zhang L; Kong L; Tong M; Shi Z; Li XM; Zhang T; Jiang Q; Biao Y
Exp Eye Res; 2023 Aug; 233():109538. PubMed ID: 37308049
[TBL] [Abstract][Full Text] [Related]
25. Multiplatform Metabolomics Reveals Novel Serum Metabolite Biomarkers in Diabetic Retinopathy Subjects.
Xuan Q; Ouyang Y; Wang Y; Wu L; Li H; Luo Y; Zhao X; Feng D; Qin W; Hu C; Zhou L; Liu X; Zou H; Cai C; Wu J; Jia W; Xu G
Adv Sci (Weinh); 2020 Nov; 7(22):2001714. PubMed ID: 33240754
[TBL] [Abstract][Full Text] [Related]
26. Global metabolomics reveals metabolic dysregulation in ischemic retinopathy.
Paris LP; Johnson CH; Aguilar E; Usui Y; Cho K; Hoang LT; Feitelberg D; Benton HP; Westenskow PD; Kurihara T; Trombley J; Tsubota K; Ueda S; Wakabayashi Y; Patti GJ; Ivanisevic J; Siuzdak G; Friedlander M
Metabolomics; 2016; 12():15. PubMed ID: 26617478
[TBL] [Abstract][Full Text] [Related]
27. Risk factors associated with diabetic retinopathy among type 2 diabetes patients at teaching hospital in Malaysia.
Abougalambou SS; Abougalambou AS
Diabetes Metab Syndr; 2015; 9(2):98-103. PubMed ID: 25470640
[TBL] [Abstract][Full Text] [Related]
28. Identification of potential plasma biomarkers and metabolic dysfunction for unstable angina pectoris and its complication based on global metabolomics.
Wang J; Xu W; Zhao H; Chen J; Zhu B; Li X; Deng D; Wang J; Liu J; Yu Y; Xiao H; Wang W
Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30770400
[TBL] [Abstract][Full Text] [Related]
29. Plasma biomarker discovery for early chronic kidney disease diagnosis based on chemometric approaches using LC-QTOF targeted metabolomics data.
Benito S; Sánchez-Ortega A; Unceta N; Jansen JJ; Postma G; Andrade F; Aldámiz-Echevarria L; Buydens LMC; Goicolea MA; Barrio RJ
J Pharm Biomed Anal; 2018 Feb; 149():46-56. PubMed ID: 29100030
[TBL] [Abstract][Full Text] [Related]
30. Importance of Identifying Novel Biomarkers of Microvascular Damage in Type 1 Diabetes.
Marcovecchio ML
Mol Diagn Ther; 2020 Oct; 24(5):507-515. PubMed ID: 32613289
[TBL] [Abstract][Full Text] [Related]
31. Diabetic retinopathy is associated with elevated serum asymmetric and symmetric dimethylarginines.
Abhary S; Kasmeridis N; Burdon KP; Kuot A; Whiting MJ; Yew WP; Petrovsky N; Craig JE
Diabetes Care; 2009 Nov; 32(11):2084-6. PubMed ID: 19675197
[TBL] [Abstract][Full Text] [Related]
32. The role of O-GlcNAc signaling in the pathogenesis of diabetic retinopathy.
Semba RD; Huang H; Lutty GA; Van Eyk JE; Hart GW
Proteomics Clin Appl; 2014 Apr; 8(3-4):218-31. PubMed ID: 24550151
[TBL] [Abstract][Full Text] [Related]
33. Plasma Metabolomics Reveals Metabolic Profiling For Diabetic Retinopathy and Disease Progression.
Sun Y; Zou H; Li X; Xu S; Liu C
Front Endocrinol (Lausanne); 2021; 12():757088. PubMed ID: 34777253
[TBL] [Abstract][Full Text] [Related]
34. Quantitative analysis of proteins in the tear fluid of patients with diabetic retinopathy.
Csősz É; Boross P; Csutak A; Berta A; Tóth F; Póliska S; Török Z; Tőzsér J
J Proteomics; 2012 Apr; 75(7):2196-204. PubMed ID: 22300579
[TBL] [Abstract][Full Text] [Related]
35. Potential Biomarkers in Diabetic Retinopathy.
Adki KM; Kulkarni YA
Curr Diabetes Rev; 2020; 16(9):971-983. PubMed ID: 32065092
[TBL] [Abstract][Full Text] [Related]
36. Biomarkers in Diabetic Retinopathy.
Jenkins AJ; Joglekar MV; Hardikar AA; Keech AC; O'Neal DN; Januszewski AS
Rev Diabet Stud; 2015; 12(1-2):159-95. PubMed ID: 26676667
[TBL] [Abstract][Full Text] [Related]
37. Diabetic retinopathy screening: global and local perspective.
Gangwani RA; Lian JX; McGhee SM; Wong D; Li KK
Hong Kong Med J; 2016 Oct; 22(5):486-95. PubMed ID: 27562988
[TBL] [Abstract][Full Text] [Related]
38. Plasma and Vitreous Metabolomics Profiling of Proliferative Diabetic Retinopathy.
Wang H; Li S; Wang C; Wang Y; Fang J; Liu K
Invest Ophthalmol Vis Sci; 2022 Feb; 63(2):17. PubMed ID: 35133401
[TBL] [Abstract][Full Text] [Related]
39. Poly(ADP-ribose) Polymerase-1: An Update on Its Role in Diabetic Retinopathy.
Sun J; Chen L; Chen R; Lou Q; Wang H
Discov Med; 2021; 32(165):13-22. PubMed ID: 35219352
[TBL] [Abstract][Full Text] [Related]
40. Intraocular fluid biomarkers (liquid biopsy) in human diabetic retinopathy.
Midena E; Frizziero L; Midena G; Pilotto E
Graefes Arch Clin Exp Ophthalmol; 2021 Dec; 259(12):3549-3560. PubMed ID: 34216255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
